Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

No doubt Sandman, ADXS is a turnaround story given the near-carcuss state O'Connor left the stock. I like Lombardo's mergers & acquisitions background. Hopefully, he steps up and strikes a large deal(s) followed by an outright sale of the company. ADXS' efforts to run itself as an independent company is getting long in the tooth, as shareholder value has eroded literally across the past 10 years. Put the company on the auction block, which will benefit patients by putting the pipeline in expert hands, and maybe shareholders will have a shot at breaking even and making a modest ROI as opposed to the alternative of kicking the can down the road further with more dilution at a low price that will erode shareholder value more.